Apple Inc may have to pay VirnetX Holding Corp more than $1.1 billion after its bid to set aside or reduce a $502.8 million patent infringement verdict was not only denied, but it was also asked to award interest and royalties.
US District Judge Robert Schroeder in Tyler, Texas rejected Apple’s request for a new trial and several claims, such as limiting VirnetX’s award to $113.7 million and that jurors should have been informed that VirnetX’s claims were “unpatentable.”
Jurors found Apple to have infringed two VirnetX patents related to virtual private networks, to which iPhone and iPad owners may connect.
The judge also awarded royalties of 84 cents per unit for future infringements, which Apple insisted should not be more than 19 cents per unit.
Shares of Apple Inc. were valued at $127.14 at the end of the trading day Monday, representing a -1.37 percent move, or $1.77 per share, on the volume of 111.6 million shares.


Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Norway Opens Corruption Probe Into Former PM and Nobel Committee Chair Thorbjoern Jagland Over Epstein Links
Federal Judge Restores Funding for Gateway Rail Tunnel Project
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Minnesota Judge Rejects Bid to Halt Trump Immigration Enforcement in Minneapolis
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
California Sues Trump Administration Over Federal Authority on Sable Offshore Pipelines
Instagram Outage Disrupts Thousands of U.S. Users
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Court Allows Expert Testimony Linking Johnson & Johnson Talc Products to Ovarian Cancer 



